0001013762-23-001574.txt : 20231004 0001013762-23-001574.hdr.sgml : 20231004 20231004160529 ACCESSION NUMBER: 0001013762-23-001574 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231002 FILED AS OF DATE: 20231004 DATE AS OF CHANGE: 20231004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DiPerna Paul CENTRAL INDEX KEY: 0001506126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41277 FILM NUMBER: 231307927 MAIL ADDRESS: STREET 1: 16772 W BERNARDO DRIVE CITY: RANCHO BERNARDO STATE: CA ZIP: 92127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Modular Medical, Inc. CENTRAL INDEX KEY: 0001074871 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870620495 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 16772 WEST BERNARDO DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 858-800-3500 MAIL ADDRESS: STREET 1: 16772 WEST BERNARDO DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: BEAR LAKE RECREATION INC DATE OF NAME CHANGE: 19981208 4 1 ownership.xml X0508 4 2023-10-02 0 0001074871 Modular Medical, Inc. MODD 0001506126 DiPerna Paul C/O MODULAR MEDICAL, INC 10740 THORNMINT ROAD SAN DIEGO CA 92127 1 1 1 0 See Remarks 0 Option to purchase common stock 1.11 2023-10-02 4 A 0 90091 1.11 A 2033-10-02 Common Stock 90091 90091 D Option to purchase common stock 1.11 2023-10-02 4 A 0 45046 1.11 A 2033-10-02 Common Stock 45046 45046 D This option shall vest as to all of the shares subject to the option if (i) all verification and validation testing for the Registrant's initial pump product is completed by December 31, 2023 and (ii) the 510(K) premarket submission to the U.S. Food and Drug Administration ("FDA") for the Registrant's initial pump product is completed by January 31, 2024. If criteria (i) and (ii) are not both achieved, the option will not vest as to any of the shares and will terminate on February 1, 2024. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in Column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class." This option shall vest as to all of the shares subject to the option if the Registrant receives notification of FDA clearance of the 510(K) premarket submission on or before August 1, 2024. If notification is not received on or before that date, the option will not vest as to any of the shares and will terminate on August 2, 2024. Chairman, President, Chief Financial Officer and Treasurer /s/ James Sullivan, attorney-in-fact for Paul DiPerna 2023-10-04